The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function

Current Biology

Volumn 7, Issue 4, 1997, Pages 270-276

  Zhang, Ying ^a   Musci, Thomas ^b   Derynck, Rik ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031128153     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(06)00123-0     Document Type: Article

References (21)

1. Kingsley DM: The TGF-β super-family: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994, 8:133-146.
2. Derynck R: TGF-β receptor-mediated signaling. Trends Biochem Sci 1994, 19:548-553.
3. Massagué J: TGFβ signaling: receptors, transducers, and Mad proteins. Cell 1996, 85:947-950.
4. Derynck R, Zhang Y: The Mad way to do it. Curr Biol 1996, 6:1226-1229.
5. Graff JM, Bansal A, Melton DA: Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta super-family. Cell 1996, 85:479-487.
6. Hoodless PA, Haerry T, Abdollah S, Stapleton M, O'Connor MB, Attisano L, et al.: MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 1996, 85:489-500.
7. Liu F, Hata A, Baker JC, Doody J, Cárcamo J, Harland RM, et al.: A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 1996, 381:620-623.
8. Newfeld SJ, Chartoff EH, Graff JM, Melton DA, Gelbart WM: Mothers against dpp encodes a conserved cytoplasmic protein required in DPP/TGF-beta responsive cells. Development 1996, 122:2099-2108.
9. Baker JC, Harland RM: A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev 1996, 10:1880-1889.
10. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, et al.: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996, 271:350-353.
11. Zhang Y, Feng X-H, Wu R-Y, Derynck R: Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature 1996, 383:168-172.
12. Thomsen GH: Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP-2/4 receptor. Development 1996, 122:2359-2366.
13. Wu R-Y, Zhang Y, Feng X-H, Derynck R: Homomeric and heteromeric interactions are required for signaling activity and functional cooperativity of Smad3 and 4. Mol Cell Biol 1997, in press.
14. Sekelsky JJ, Newfeld SJ, Raftery LA, Chartoff EH, Gelbart WM: Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 1995, 139:1347-1358.
15. Gorlich D, Mattaj IW: Nucleocytoplasmic transport. Science 1996, 271:1513-1518.
16. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, et al.: MADR2 maps to 18q21 and encodes a TGF-β-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 1996, 86:543-552.
17. Lagna G, Hata A, Hemmati-Brivanlou A, Massagué J: Partnership between DPC 4 and SMAD proteins in TGF-β signalling pathways. Nature 1996, 383:832-836.
18. Feng XH, Filvaroff EH, Derynck R: Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors. J Biol Chem 1995, 270:24237-24245.
19. Hemmati-Brivanlou A, Melton DA: Inhibition of activin receptor signaling promotes neuralization in Xenopus. Cell 1994, 77:273-281.
20. Graff JM, Thies RS, Song JJ, Celeste AJ, Melton DA: Studies with a Xenopus BMP receptor suggest that ventral mesoderm-inducing signals override dorsal signals in vivo. Cell 1994, 79:169-179.
21. Keeton MR, Curriden SA, van Zooneveld AJ, Loskutoff DJ: Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta. J Biol Chem 1991, 266:23048-23052.